Latest & greatest articles for gestational diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for gestational diabetes

121. Cohort study: Gestational diabetes is associated with increased risk of urinary incontinence up to 2?years postpartum

Cohort study: Gestational diabetes is associated with increased risk of urinary incontinence up to 2?years postpartum Gestational diabetes is associated with increased risk of urinary incontinence up to 2 years postpartum | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Gestational diabetes is associated with increased risk of urinary incontinence up to 2 years postpartum Article Text Midwifery Cohort study Gestational diabetes is associated

2014 Evidence-Based Nursing

122. Systematic review with meta-analysis: Treating mild gestational diabetes yields benefits with little or no evidence of harms

Systematic review with meta-analysis: Treating mild gestational diabetes yields benefits with little or no evidence of harms Treating mild gestational diabetes yields benefits with little or no evidence of harms | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Treating mild gestational diabetes yields benefits with little or no evidence of harms Article Text Therapeutics Systematic review with meta-analysis Treating mild gestational

2014 Evidence-Based Medicine (Requires free registration)

123. Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force. (Full text)

Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force. A 50-g oral glucose challenge test (OGCT) is a widely accepted screening method for gestational diabetes mellitus (GDM), but other options are being considered.To systematically review the test characteristics of various screening methods for GDM across a range of recommended diagnostic glucose thresholds.15 electronic databases from 1995 to May 2012, reference lists, Web sites of relevant (...) , respectively. At a threshold of 7.2 mmol/L (130 mg/dL), the test characteristics were 88% to 99%, 66% to 77%, 2.7 to 4.2, and 0.02 to 0.14, respectively. For a fasting plasma glucose threshold of 4.7 mmol/L (85 mg/dL), they were 87%, 52%, 1.8, and 0.25, respectively. Glycated hemoglobin level had poorer test characteristics than fasting plasma glucose level or the OGCT. No studies compared the OGCT with International Association of the Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria.The

2013 Annals of Internal Medicine PubMed

124. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. (PubMed)

Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Outcomes of treating gestational diabetes mellitus (GDM) are not well-established.To summarize evidence about the maternal and neonatal benefits and harms of treating GDM.15 electronic databases from 1995 to May 2012, gray literature, Web sites of relevant organizations (...) ), induction of labor (insufficient evidence), small-for-gestational-age neonates (moderate evidence), or admission to a neonatal intensive care unit (low evidence).Evidence is low or insufficient for many outcomes of greatest clinical importance. The strongest evidence supports reductions in intermediate outcomes; however, other factors (for example, maternal weight and gestational weight gain) may impart greater risk than GDM, particularly when glucose levels are modestly elevated.Treating GDM results

2013 Annals of Internal Medicine

125. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the US Preventive Services Task Force and National Institutes of Health Office of Medical Applications of Research

Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the US Preventive Services Task Force and National Institutes of Health Office of Medical Applications of Research Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the US Preventive Services Task Force and National Institutes of Health Office of Medical Applications of Research Benefits and harms of treating gestational diabetes mellitus (...) : a systematic review and meta-analysis for the US Preventive Services Task Force and National Institutes of Health Office of Medical Applications of Research Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L CRD summary This well-conducted review concluded that treating gestational diabetes mellitus resulted in less pre-eclampsia, shoulder dystocia and macrosomia compared with no treatment. The evidence did not show an effect on neonatal hypoglycaemia or future poor metabolic outcomes

2013 DARE.

126. Screening tests for gestational diabetes: a systematic review for the US Preventive Services Task Force

Screening tests for gestational diabetes: a systematic review for the US Preventive Services Task Force Screening tests for gestational diabetes: a systematic review for the US Preventive Services Task Force Screening tests for gestational diabetes: a systematic review for the US Preventive Services Task Force Donovan L, Hartling L, Muise M, Guthrie A, Vandermeer B, Dryden DM CRD summary This review concluded that the oral glucose challenge test and fasting plasma glucose could identify women (...) without gestational diabetes mellitus, and the challenge test was better at identifying women with the condition. Despite some data issues, such as low quality and a variety of reference standards, this review was well conducted and these conclusions are likely to be reliable. Authors' objectives To assess the accuracy of various screening tests, in detecting gestational diabetes mellitus, across a range of recommended diagnostic glucose thresholds. Searching Fifteen databases, including MEDLINE

2013 DARE.

127. Insufficient evidence for exercise preventing gestational diabetes mellitus

Insufficient evidence for exercise preventing gestational diabetes mellitus Insufficient evidence for exercise preventing gestational diabetes mellitus | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Insufficient evidence for exercise preventing gestational diabetes mellitus Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2013 Cochrane PEARLS

128. Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes. (PubMed)

Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes. Gestational diabetes mellitus (GDM) is associated with adverse health outcomes for both mother and infant both perinatally and long-term. Women with a history of GDM are at risk of recurrence in subsequent pregnancies and may benefit from intervention in the interconception period to improve maternal and infant health outcomes.To investigate the effects of interconception care (...) assessed study eligibility. In future updates of this review, at least two review authors will extract data and assess the risk of bias of included studies.One ongoing trial was identified. No eligible completed trials were identified.The role of interconception care for women with a history of gestational diabetes remains unclear. Randomised controlled trials are required evaluating different forms and protocols of interconception care for these women on perinatal and long-term maternal and infant

2013 Cochrane

129. Fasting Plasma Glucose at 24-28 Weeks to Screen for Gestational Diabetes Mellitus: New evidence from China (Full text)

Fasting Plasma Glucose at 24-28 Weeks to Screen for Gestational Diabetes Mellitus: New evidence from China To evaluate the usefulness of a fasting plasma glucose (FPG) at 24-28 weeks' gestation to screen for gestational diabetes mellitus (GDM).The medical records and results of a 75-g 2-h oral glucose tolerance test (OGTT) of 24,854 pregnant women without known pre-GDM attending prenatal clinics in 15 hospitals in China were examined.FPG cutoff value of 5.1 mmol/L identified 3,149 (12.1 (...) %) pregnant women with GDM. FPG cutoff value of 4.4 mmol/L ruled out GDM in 15,369 (38.2%) women. With use of this cutoff point, 12.2% of patients with mild GDM will be missed. The positive predictive value is 0.322, and the negative predictive value is 0.928.FPG at 24-28 weeks' gestation could be used as a screening test to identify GDM patients in low-resource regions. Women with an FPG between ≥4.4 and ≤5.0 mmol/L would require a 75-g OGTT to diagnose GDM. This would help to avoid approximately one

2013 EvidenceUpdates PubMed

130. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin (PubMed)

Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin We compared metformin with insulin as treatment of gestational diabetes mellitus (GDM). Furthermore, we aimed to characterize metformin-treated patients needing additional insulin to achieve prespecified glucose targets.We conducted a single centre randomized controlled study with non-inferiority design comparing metformin and insulin in the treatment of 217 GDM (...) additional insulin were older (p = 0.04), their oral glucose tolerance test had been performed earlier and diabetes therapy started earlier in gestation (p = 0.01 and p = 0.004, respectively). The risk for additional insulin was 4.6-fold in women with baseline serum fructosamine concentration above median compared with those below median.Metformin is an effective alternative to insulin in the treatment of GDM patients. Serum fructosamine may help in predicting the adequacy of metformin treatment alone.©

2013 EvidenceUpdates

131. Evaluation of the Value of Fasting Plasma Glucose in First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China (Full text)

Evaluation of the Value of Fasting Plasma Glucose in First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China To evaluate the value of fasting plasma glucose (FPG) value in the first prenatal visit to diagnose gestational diabetes mellitus (GDM).Medical records of 17,186 pregnant women attending prenatal clinics in 13 hospitals in China, including the Peking University First Hospital (PUFH), were examined. Patients with pre-GDM were excluded; data for FPG at the first prenatal (...) visit and one-step GDM screening with 75-g oral glucose tolerance test (OGTT) performed between 24 and 28 weeks of gestation were collected and analyzed.The median ± SD FPG value was 4.58 ± 0.437. FPG decreased with increasing gestational age. FPG level at the first prenatal visit was strongly correlated with GDM diagnosed at 24-28 gestational weeks (χ(2) = 959.3, P < 0.001). The incidences of GDM were 37.0, 52.7, and 66.2%, respectively, for women with FPG at the first prenatal visit between 5.10

2013 EvidenceUpdates PubMed

132. Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria

Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2013 DARE.

133. Randomised controlled trial: Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)?

Randomised controlled trial: Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? Article Text Therapeutics Randomised controlled trial Should

2013 Evidence-Based Medicine (Requires free registration)

134. Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? (Full text)

Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Werner EF (...) , Funai EF, Pettker CM, Henderson J, Zuckerwise L, Thung SF, Reel M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of criteria for the diagnosis of gestational diabetes mellitus, as proposed

2013 NHS Economic Evaluation Database. PubMed

135. Screening and diagnosing gestational diabetes mellitus

Screening and diagnosing gestational diabetes mellitus Screening and diagnosing gestational diabetes mellitus Screening and diagnosing gestational diabetes mellitus Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L Citation Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L. Screening and diagnosing gestational diabetes mellitus. Rockville: Agency for Healthcare Research and Quality (AHRQ (...) for offspring as a result of GDM and its treatment, and the "real world" effects of GDM treatment on use of care. Final publication URL Additional data URL Indexing Status Subject indexing assigned by CRD MeSH Diabetes, Gestational; Mass Screening; Pregnancy Complicationss Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence AHRQ, Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road

2012 Health Technology Assessment (HTA) Database.

136. No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk for gestational diabetes: results of a randomised controlled trial (Full text)

No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk for gestational diabetes: results of a randomised controlled trial To evaluate the effectiveness of an exercise programme for pregnant women who were overweight or obese and at risk for gestational diabetes mellitus (GDM).Randomised controlled trial.Hospitals and midwifery practices in the Netherlands.Pregnant women who were overweight or obese

2012 EvidenceUpdates PubMed

137. The usefulness of HbA1c in postpartum reclassification of gestational diabetes. (Full text)

The usefulness of HbA1c in postpartum reclassification of gestational diabetes. To investigate the role of HbA1c in postpartum reclassification of gestational diabetes (GDM) we studied 364 women with GDM attending the postpartum reclassification assessment of their glucose tolerance status. A 75-g oral glucose tolerance test (OGTT) was performed and HbA1c was determined. Diabetes was diagnosed in 12 (3.3%), 7 (1.9%) and 2 (0.6%) women according to the fasting plasma glucose (FPG) and/or the 2 (...) -hour OGTT, the FPG alone and HbA1c levels, respectively. The sensitivity and specificity for HbA1c to diagnose diabetes was 16.7% and 100%, respectively, for FPG and OGTT criteria. The combination of a cutoff value of 5.5% for HbA1c and FPG allowed us to identify 95.1% of women with any kind of glucose intolerance. We conclude that in the early postpartum period, the cutoff of 6.5% for HbA1c alone has low sensitivity for the diagnosis of diabetes compared with OGTT, but the combination of FPG

2012 EvidenceUpdates PubMed

138. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review (Full text)

Glucose challenge test for detecting gestational diabetes mellitus: a systematic review The best strategy to identify women with gestational diabetes mellitus (GDM) is unclear.To perform a systematic review to calculate summary estimates of the sensitivity and specificity of the 50-g glucose challenge test for GDM.Systematic search of MEDLINE, EMBASE and Web of Science.Articles that compared the 50-g glucose challenge test with the oral glucose tolerance test (OGTT, with a 75- or 100-g

2012 EvidenceUpdates PubMed

139. Interventions for preventing gestational diabetes mellitus: A systematic review and meta-analysis

Interventions for preventing gestational diabetes mellitus: A systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2012 DARE.

140. Treating mild gestational diabetes mellitus: a cost-effectiveness analysis (Full text)

Treating mild gestational diabetes mellitus: a cost-effectiveness analysis Treating mild gestational diabetes mellitus: a cost-effectiveness analysis Treating mild gestational diabetes mellitus: a cost-effectiveness analysis Ohno MS, Sparks TN, Cheng YW, Caughey AB Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical (...) assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the cost-effectiveness of treatment for mild gestational diabetes mellitus, from a societal perspective. The authors concluded that treatment for mild gestational diabetes improved both maternal and neonatal outcomes and was cost-effective. The cost-effectiveness framework was valid and the authors’ conclusions appear to be robust, but more detail on the data sources would have been useful. Type

2012 NHS Economic Evaluation Database. PubMed